Nearly 5 million American are currently diagnosed with heart failure. It is now known that after an inciting cardiac insult the myocardium hypertrophies, subsequently followed by contractile dysfunction and myocardial failure. The fundamental changes in the contractile function of myocardial hypertrophy are not well understood. Valvular heart disease enables the study of human hypertrophied myocardium by obtaining myocardial biopsies at the time of valve replacement. We plan to investigate the molecular basis of altered contractile function in the most prevalent of valvular diseases - aortic stenosis, aortic insufficiency, and mitral regurgitation. Isolated myofibrils will be studied mechanically to provide a detailed characterization of altered contractile protein function within the spatial constraints of the structured myofilament lattice. Native thin filament function will be directly assessed using the in vitro motility assay in order to identify and measure the extent to which changes in thin filament function contribute to the disruption of mechanical function at the myofibrillar level. The functional contribution of phosphorylation will be determined through the mechanical assessment of myofibrils and native thin filaments before and after phosphatase treatment. Finally, mass spectrometry will be used with the specific focus of quantitating changes in phosphorylation of two regulatory proteins associated with the thin filament - troponin I and troponin T. Through this approach investigation of other post-translational changes can also be pursued as dictated by the mechanical studies. This will be the first use of cardiac native thin filaments and myofibrils to study mechano-chemical alterations of contractile proteins produced by human valvular heart disease. The goal of this study is to test the hypothesis that, during the initial stages of hypertrophy, the primary alterations in contractile function originate in thin filament proteins, and that changes in regulatory protein phosphorylation plays a major role in the progression from non-failing non-hypertrophied myocardium to end-stage failing myocardium.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL077637-02
Application #
6943893
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Evans, Frank
Project Start
2004-09-01
Project End
2008-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
2
Fiscal Year
2005
Total Cost
$378,750
Indirect Cost
Name
University of Vermont & St Agric College
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Hefer, David; Yi, Ting; Selby, Donald E et al. (2012) Erythropoietin induces positive inotropic and lusitropic effects in murine and human myocardium. J Mol Cell Cardiol 52:256-63
Vanburen, Peter; Ma, Jun; Chao, Samuel et al. (2011) Blood gene expression signatures associate with heart failure outcomes. Physiol Genomics 43:392-7
Vanburen, Peter; Palmer, Bradley M (2010) Cooperative activation of the cardiac myofilament: the pivotal role of tropomyosin. Circulation 121:351-3
Hunlich, Mark; Tremble, Sarah M; Begin, Kelly J et al. (2010) Atrial contractile protein content and function are preserved in patients with coronary artery disease and atrial fibrillation. Coron Artery Dis 21:357-62
Debold, Edward P; Saber, Walid; Cheema, Yaser et al. (2010) Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro. J Mol Cell Cardiol 48:286-92
Rachdaoui, Nadia; Austin, Leanne; Kramer, Eric et al. (2009) Measuring proteome dynamics in vivo: as easy as adding water? Mol Cell Proteomics 8:2653-63
Okada, Yoko; Toth, Michael J; Vanburen, Peter (2008) Skeletal muscle contractile protein function is preserved in human heart failure. J Appl Physiol 104:952-7
Saber, Walid; Begin, Kelly J; Warshaw, David M et al. (2008) Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay. J Mol Cell Cardiol 44:1053-61
Previs, Michael J; VanBuren, Peter; Begin, Kelly J et al. (2008) Quantification of protein phosphorylation by liquid chromatography-mass spectrometry. Anal Chem 80:5864-72
VanBuren, Peter; Okada, Yoko (2005) Thin filament remodeling in failing myocardium. Heart Fail Rev 10:199-209

Showing the most recent 10 out of 12 publications